| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |